单极抑郁和双极抑郁之间的生物标志物的差异:一个元分析
Xiaomin Yang1, Qiong Tang1, Rongfeng Xiang1
1The Second Department of Severe Psychiatry, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, Sichuan, 621000, China.
Journal of affective disorders
|October 10, 2025
概括
双极性抑郁症 (BDD) 患者与单极性抑郁症 (UD) 患者相比,表现出更高的白血球,中性粒细胞数量,尿酸和白蛋白水平. 患有BDD的患者也有较低的血小板数量和来自大脑的神经营养因子,这表明潜在的诊断生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
- 精神病学是一个精神病学.
背景情况:
- 在临床上区分单极性抑郁症 (UD) 和双极性抑郁症 (BDD) 是有意义的.
- 周围血液生物标志物为客观诊断措施提供了潜在的途径.
研究的目的:
- 进行元分析,比较UD和BDD患者之间的外周血液生物标志物水平.
- 为了确定UD和BDD的差异诊断的潜在生物标志物.
主要方法:
- 在PubMed,Embase,Cochrane图书馆和Web of Science数据库中进行系统的文献搜索,截至2024年8月.
- 使用 Stata 15.1 的元分析来计算加权平均差异 (WMD) 和 95% 置信区间 (CI).
- 包括31项研究,包括24,923名患者.
主要成果:
- 双极性抑郁症 (BDD) 患者与单极性抑郁症 (UD) 患者相比,表现出明显更高的白血细胞 (WBC),中性粒细胞数 (NC),尿酸 (UA) 和白蛋白水平.
- 相反,BDD患者的血小板计数 (PC) 和来自大脑的神经营养因子 (BDNF) 水平明显低于UD患者.
- 针对每个生物标志物报告了特定的WMD和CI,表明了统计学上显著的差异.
结论:
- 与UD相比,BDD与截然不同的外周血液生物标志物概况有关.
- 在BDD患者中,升高的IL-6,WBC,NC,UA,albumin以及降低的PC和BDNF水平可能是潜在的诊断指标.
- 这些发现凸显了外围生物标志物在区分UD和BDD方面的实用性.
相关概念视频
01:30Bipolar Disorder
619
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
619
01:18Depression: Overview
781
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
781
01:27Depressive Disorders: Etiology
441
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
441
01:23Antidepressant Drugs: MAOIs and Other Agents
823
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
823
01:27Depressive Disorders: MDD and Dysthymia
649
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
649